As of 2026-01-05, the Relative Valuation of Mesa Laboratories Inc (MLAB) is 19.28 USD. This relative valuation is based on P/E multiples. With the latest stock price at 79.43 USD, the upside of Mesa Laboratories Inc based on Relative Valuation is -75.7%.
The range of the Relative Valuation is (9.54) - 51.07 USD.
| Range | Selected | |
| Trailing P/E multiples | 33.5x - 34.9x | 33.9x |
| Forward P/E multiples | 31.0x - 35.2x | 33.2x |
| Fair Price | (9.54) - 51.07 | 19.28 |
| Upside | -112.0% - -35.7% | -75.7% |
| Date | P/E |
| 2026-01-02 | -278.91 |
| 2025-12-31 | -275.65 |
| 2025-12-30 | -276.00 |
| 2025-12-29 | -280.85 |
| 2025-12-26 | -282.57 |
| 2025-12-24 | -283.27 |
| 2025-12-23 | -284.50 |
| 2025-12-22 | -284.50 |
| 2025-12-19 | -284.57 |
| 2025-12-18 | -283.02 |
| 2025-12-17 | -280.11 |
| 2025-12-16 | -276.11 |
| 2025-12-15 | -273.30 |
| 2025-12-12 | -273.09 |
| 2025-12-11 | -276.00 |
| 2025-12-10 | -278.00 |
| 2025-12-09 | -273.44 |
| 2025-12-08 | -273.79 |
| 2025-12-05 | -272.59 |
| 2025-12-04 | -270.91 |
| 2025-12-03 | -268.20 |
| 2025-12-02 | -267.08 |
| 2025-12-01 | -276.28 |
| 2025-11-28 | -281.62 |
| 2025-11-26 | -282.71 |
| 2025-11-25 | -285.02 |
| 2025-11-24 | -272.98 |
| 2025-11-21 | -247.91 |
| 2025-11-20 | -251.42 |
| 2025-11-19 | -248.33 |
| 2025-11-18 | -247.94 |
| 2025-11-17 | -251.49 |
| 2025-11-14 | -259.64 |
| 2025-11-13 | -266.38 |
| 2025-11-12 | -280.56 |
| 2025-11-11 | -281.09 |
| 2025-11-10 | -287.34 |
| 2025-11-07 | -266.91 |
| 2025-11-06 | -262.90 |
| 2025-11-05 | -260.55 |
| 2025-11-04 | -258.93 |
| 2025-11-03 | -258.27 |
| 2025-10-31 | -252.44 |
| 2025-10-30 | -266.94 |
| 2025-10-29 | -269.36 |
| 2025-10-28 | -273.58 |
| 2025-10-27 | -269.98 |
| 2025-10-24 | -278.00 |
| 2025-10-23 | -276.28 |
| 2025-10-22 | -273.61 |